Hereditäres Angioödem: Donidalorsen im Handel Mit Donidalorsen ist ein weiteres Medikament zur Prophylaxe von Attacken des hereditären Angioödems (HAE) verfügbar. Das Antisense-Olig...

Mit #Donidalorsen ist ein weiteres Medikament zur Prophylaxe von Attacken des hereditären Angioödems #HAE verfügbar. Das Antisense-Oligonukleotid senkte in Studien die Häufigkeit der Attacken um 81 Prozent und kann ab einem Alter von zwölf Jahren eingesetzt werden.

Donidalorsen Reduces Creatine Kinase and Points to Muscle Instability in HAE Long-term prophylaxis with donidalorsen every 4 weeks significantly reduced creatine kinase in patients with hereditary angioedema.

Long-term prophylaxis with #Donidalorsen administration every 4 weeks was associated with a significant reduction in creatine kinase levels in patients with #HereditaryAngioedema (HAE). Study in World Allergy Organization Journal.

Read more: https://bit.ly/4sgeQDm

#RareDisease #HAE

Angioedema ereditario, ok Ue a prima terapia preventiva mirata all'Rna (Adnkronos) - La Commissione europea ha concesso l'autorizzazione alla commercializzazione di donidalorsen per la profilassi a lungo termine degli attacchi ricorrenti dell'angioedema ereditario (Hae) negli adulti e negli adolescenti con...

Angioedema ereditario, ok Ue a prima terapia preventiva mirata all'Rna ... LEGGI TUTTO #Angioedema #Ereditarietà #Salute #Terapia #Donidalorsen

Following FDA approval, #donidalorsen (Dawnzera) shows strong efficacy and safety in patients switching from other #HAE prophylactic therapies.
William Lumry, MD, discusses pivotal switch data and real-world impact: www.hcplive.com/view/switchi...

#hereditaryangioedema #HAE #chronicillness #Dawnzera #donidalorsen #raredisease #preventivecare #BioNews #AngioedemaNews

#HAE #HaeNews #HereditaryAngioedema #Donidalorsen #RareDisease #MedicalBreakthrough #ChronicIllness #HAECommunity #AngioedemaNews #BioNews